FDA Greenlights Phase 1 Trial of Narcolepsy Drug Candidate ORX750
The clinical trial will evaluate the safety, tolerability, and pharmacokinetics of Centessa Pharmaceuticals’ orexin receptor 2 agonist.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
